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Summary.-Nuclear and cytoplasmic oestrogen receptors (REN and REc) were
sought in 5 normal cervices and in 43 specimens of squamous carcinoma of the
cervix. All 3 tissue components of the 5 normal cervices contained both REN and REc.
Thirty-five (81%) of the tumours contained receptors, but in only 9 (21%) were they
found in both subcellular compartments. Twenty-four tumours (56%) had only REc
and 2 had only REN. The potential therapeutic significance of these findings is not yet
known, but it seems possible that tumours with an intact receptor mechanism might
benefit from oestrogen therapy and have a more favourable prognosis.
ALL THREE TISSUE COMPONENTS of the
normal cervix respond to oestrogens.
Thus the growth of cervical stroma at
puberty, during pregnancy and during
oral contraceptive usage, the mid-cycle
secretion of mucus by the columnar
epithelium of the endocervix, and the
growth of the squamous epithelium itself
that may be seen on the atrophic post-
menopausal cervix treated with hormone
replacement are all due to oestrogens.
Invasive squamous carcinoma ofthe cervix
develops from abnormal squamous meta-
plasia in the transformation zone pre-
viously created by oestrogen-promoted
stromal hypertrophy and consequent ever-
sion of the endocervix. This study of
oestrogen receptors was begun in order to
determine whether oestrogens play any
part in the transition from normal to
neoplastic tissue in the human cervix.
Nuclear and cytoplasmic receptors (REN
anid REC, respectively) were measured
because of the extensive evidence in
animals (Anderson et al., 1974, 1975;
O'Malley & Means, 1974) and in humans
(McGuire et al., 1978; Barnes et al., 1979)
that it is the nuclear-bound oestrogen
receptor that is responsible for effecting
the expression of oestrogenic stimulation.
An intact RE mechanism in breast cancer
implies an improved prognosis (Leake et
al., 1981a) and a high probability of
response to endocrine therapy, if required
(Leake et al., 1981b). If REs are present in
squamous cervical cancer, and have the
same significance, the clinical value of
these observations wouldbe considerable.
MATERIALS AND METHODS
The uteri from 5 women undergoing
hysterectomy for fibroids were obtained
immediately after removal. Endometrium
was scraped out of the uterine cavity and
samples of endocervical, ectocervical and
stromal tissue were dissected from the cervix,
placed in buffered saline (BS: 0-15M NaCl,
20mM Hepes, pH 7.4) on ice and transported
to the laboratory for immediate assay. The
uterus was sent for routine histological
examination to confirm the normality of the
tissues obtained.
Biopsy specimens were obtained from the
tumours of 43 women with squamous car-
cinoma ofthe cervix. One portion was placed
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in formol saline for histological confirmation
of the diagnosis, and the remainder was
transported immediately to the laboratory
in BS on ice. From those biopsy specimens
that were large enough, another portion of
the tumour, adjacent to the part that -would
be assayed, was placed in formol saline for a
histological assessment of the proportion of
tumour cells in the sample. The remaining
tissue was either assayed immediately or
stored in liquid N2 for not more than 4
weeks.
[2,4,6,7-3H]-Oestradiol-17g (85-110 Ci/
mmol) was obtained from the Radiochemical
Centre, Amersham, and its purity confirmed
by ascending paper chromatography (Bush,
1952). Unlabelled steroids were obtained from
Sigma Co. (St Louis. Missouri, U.S.A.) and,
unless otherwise stated, all other chemicals
were obtained from E. Merck (Darmstadt,
Germany). The assay has been described in
detail previously (Soutter et al., 1979; Pego-
raro et al., 1980) and therefore will be outlined
only briefly here, indicating modifications in
technique. Normal stroma and squamous
epithelium were more readily homogenized,
using a microdismembrator (Braun, Melsunge,
West Germany) but less fibrous tissues from
the endometrium, the endocervix and most
tumour samples were disrupted using a
Teflon-glass homogenizer. The homogenizing
buffer (HED) used was: 20mM Hepes;
1 5mM EDTA; 0 25mM dithiothreitol; pH
7-4. Only 150 mg of tissue (50 mg/ml HED)
was required for a full assay. A crude nuclear
pellet was prepared by centrifugation at
700 g for 10 min, the supernatant was de-
canted and a portion stored at -20°C for
protein estimation by Lowry's method. The
crude nuclear pellet was washed once in BS
and then resuspended in 0-15M NaCl, 20mM
Hepes, pH 6-2, and an aliquot kept at -200C
for DNA estimation (Katzenellenbogen &
Leake, 1974). The binding of [3H]-oestradiol-
17/3 in both the 7OOg supernatant (cytoplasmic
binding) and in the resuspended nuclear
pellet was measured in 8 150l portions after
incubation for 18 h at 40C with [3H]-oestra-
diol-173 at final concentrations from 0-1 to
0 8nM. An additional portion from both frac-
tions was incubated with 0 8nM [3H]-
oestradiol-17f plus a 100-fold excess of non-
radioactive diethylstilboestrol to measure
nonspecific binding. Appropriate blanks were
included in the cytoplasmic assay. Free and
loosely bound ligand wias removed from the
cytoplasmic preparation by dextran-coated
charcoal, and from the nuclear suspension by
washing with 20 ml 015M NaCl on Whatman
GF/C filters using a Millipore filter unit. Total
and bound radioactivity were measured in a
Packard Tricarb 3390, using Instagel (Pack-
ard) as scintillant, at average efficiencies of
26% for the cytoplasmic assay and 42% for
the nuclear assay. The data was plotted
according to Scatchard (1949) and a straight
line was drawn bythe method ofleast squares,
using the linear part of the plot. The correla-
tion coefficient of this line was required to be
significant to the 5%o level. The number of
binding sites was calculated from the inter-
cept of this line and the abscissa, and the
dissociation constant, which is inversely
proportional to the strength of the binding
measured, was calculated from the reciprocal
of the slope. Receptors were deemed to be
present if the dissociation constant was less
than 8 x 10-10M. Thus it was possible in
every case to measure the number ofreceptors
present, and the strength ofthe binding.
TABLE I.-Mean (s.e.) oestrogen-receptor concentrations and dissociation constants in
normal uterine tissue
REC
(fmol/mg
No. protein)
5
5
5
5
156 (46)
89 (37)
86 (36)
51 (18)
REN
(fmol/mg
KD No. DNA)
0 58 (0.21)
2 17 (0 55)
2 25 (0 67)
3*44 (1.12)
5
4*
5
4*
595 (374)
414 (79)
664 (88)
1003 (234)
KD
1 99 (0 74)
3.40 (0-85)
3 04 (1-01)
3 49 (0.79)
KD = Dissociation constant x 10-10N.
* One nuclear assay from this group was teclnically tinsatisfactory.
Endometrium
Endocervix
Ectocervix
Stroma
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RESULTS
All 3 components of the 5 normal
cervices contained both REN and REC
(Table I). Although there seemed to be
lower concentrations of REc in the cer-
vical tissues than in the endometrium, no
such difference was apparent for REN.
In contrast, samples of squamous car-
cinoma contained both REs in only 21%
TABLE II.-Oestrogen receptors insquamous
carcinoma ofthe cervix
No. %
9 20-9
24 55-8
2 4-7
8 18-6
43 100
KD REN
2-19 181
0-24 29-6
0 30-6 28 61-397
33 11
KD
0*88
4-38
2 80
5-26
2-98
2-35
0-59
2-11
1-70
3-21
4 30
0-30
5-57
3-61
6-84
2-87
0*58
1-02
5-66
2-24
4 60
KD
2-76
0-26
1-53-4-47
11
REN KD
144 2-64
260 4 80
0
0
0
0
0
0
88 1-82
159 2-72
0
0
0 _
0
0
0
unsatisfactory assay
397 3-18
182 2-87
146 2-78
0?
0?
0
0
0
0
TABLE V.-Oestrogen receptors in squamous
carcinoma of the cervix compared with
the histological assessment of the percen-
tage oftumour cells in the sample
Tumour
cells REC REN
45 15 0
50 31 203
50 11 0
50 23 0
55 5 160
60 27 196
60 18 0
65 24 0
70 0 0
75 22 0
75 27 0
80 0 0
80 0 0
80 45 0
80 62 0
80 38 397
85 96 132
90 0 182
90 23 159
90 37 144
90 36 0
90 0 0
90 0 320
95 16 0
95 0 0
95 0 0
100 16 0
100 0 0
100 10 0
100 16 0
100 19 0
100 30 0
100 53 0
of cases, REC alone in 56% of cases and
REN alone in 2 specimens (4.7%) (Table
II). The levels ofRE concentrations found
were lower than in normal cervical tissue
(Table III). Twelve samples were large
enough to be assayed more than once
(Table IV). Ten contained REC on each
occasion they were assayed, and 2 con-
tained REN on each occasion. One tumour
was assayed 4 times, and evidence of
nuclear binding was found every time.
However, the line drawn on the Scatchard
plot was not quite significant at the 5%
level on two of these occasions, so those
assays were reported as negative. In one
ofthe 4 replicate cytoplasmic assays, a low
concentration ofbinding was found. These
werethe onlyexamplesofnon-concordance
ofresults. There was no evidence ofdegra-
REC/REN
+I+
+l-
-I+
Total
TABLE III.-Oestrogen-receptor concentra-
tions and dissociation constants in squa-
mous carcinoma of the cervix
Mean
S.e.
Range
n
REC
26-8
3-3
5-96
33
TABLE IV.-The results of replicate assays
ofsquamous carcinoma
Patient REC
J.N. 63
51
C.S. 18
25
M.T. 11
12
B.D. 15
27
I.H. 9
23
P.D. 23
59
L.S. 45
39
S.M. 62
30
P.M. 45
38
R.Z. 0
13
0
0
P.D. 0
0
R.M. 16
30
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B/F
A 1.0-
0
0.5-
50 160 150
fmollml
0.06-
B
0.03-
0
5 10
fmol/mI
FIG. 1. Scatchard plots of cytoplasmic (A)
and nuclear (B) binding of oestradiol-17#
in squamous carcinoma of cervix, showing
high-affinity receptors in both subcellular
compartments. REc =95 fmol/mg protein;
KD=0 76x10 10M; REN==132 fmol/mg
DNA; KD= 1-53 x 10-10M.
dation of receptors during storage in
liquid N2. Examples of Scatchard plots
ofthe data are shown in Figs 1-3.
In 33 samples there was enough tissue
in the biopsy portion for a histological
assessment of the proportion of malignant
cells. In 16 of these, 90% or more of the
sample consisted of tumour; in 12,
60-85% and in 5, 45-55% of the cells
seen were neoplastic. The proportion of
tumour cells present, within these limits,
seemed not to affect the results ofreceptor
measurement (Table V).
DISCUSSION
The limited study of normal cervical
tissues reported here was intended only to
demonstrate that oestrogen receptors are
normally present in the nucleus of the cell
as well as in the cytoplasm. The cytoplas-
A
fmol/mi
0.04-
B
0.02-
0
* 0
0
0
0 0
10 20 30
fmol/mI
FIG. 2.-Scatchard plots of cytoplasmic (A)
and nuclear (B) binding of oestradiol-17,
in squamous carcinoma of cervix, showing
high-affinity receptors in the cytosol only.
REc= 19 fmol/mg protein; KD= 1-9 X
10-10M.
mic levels found are similar to those
demonstrated by Sanborn et al. (1978).
In earlier studies of carcinoma of the
cervix, a smaller proportion of tumours
showed evidence of oestrogen binding.
Whole-tissue uptake studies showed low
levels of binding in 10 out of 26 samples
(Terenius et al., 1971). REC measurement
gave positive results at very low levels of
binding in 17% of 42 samples ofsquamous
carcinoma but in 3 of 4 samples of adeno-
carcinoma of the cervix (Hahnel et al.,
1979). However, in a study of several
tissues and tumours, the 3 samples of
carcinoma of cervix which were assayed
were all found to contain REC (Syrjala
et al., 1978).
Since the assay used in this study was
able to detect receptors in normal tissue,
it might have been possible that the low
levels of receptors found in the tumours
were due to an admixture of normal cells
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B/1
F
A 0.05- * *
20 40
fmol/ml
B 0.10
0.05
0
0
10 20 30
fmollml
FIG. 3.- Scatchard plots of cytoplasmic (A)
and niuclear (B) binding of oestradiol-17f
in squamous carcinoma of cervix, showing
high-affinity receptors in the nucleus only.
REN=320 fmol/mg DNA; KD=2-75x
10-10 M.
in the biopsy specimen. The histological
assessment of this "contamination"
showed that in most cases the amount of
normal tissue was too small to account
for the concentrations ofreceptordetected;
nor was there any correlation between the
percentage of tumour cells in the biopsy
specimen and the receptor concentration.
Thus it seems unlikely that the receptors
detected in biopsy specimens of tumour
tissue were present only in normal cells
contained in the sample.
The use of strict criteria for a positive
result may have led to some assays being
declared negative when receptors were in
fact present. The opposite error was less
likely. This is borne out by the good
replication found in samples assayed more
than once.
Tumours containing both REs may be
susceptible to oestrogen regulation.
Seventy-one per cent of breast cancers
with this receptor configuration respond
to endocrine therapy (Leake et al., 1981b).
Tumours with cytoplasmic but no nuclear
binding may have abnormal receptors
that are incapable of translocation to the
nucleus. This type of tumour is much less
common in breast cancer, whereitaccounts
for only 12-17% of cases (Leake et al.,
1981b; Pegoraro et al., 1980) of which a
surprisingly high 24% respond to endo-
crine therapy (Leake et al., 1981b). The
interesting tumours with receptor found
only in the nucleus remain an enigma in
breast (Leake et al., 1981b) and in cervical
carcinoma, and challenge current concepts
of oestrogen action. Few breast tumours
of this type respond to endocrine therapy
(Leake et al., 1981b). Similarly, by extra-
polation from breast-cancer experience,
few tumours with no evidence of RE in
either compartment would be expected to
respond to endocrine therapy and might
be expected to carry a poorer prognosis
(Leake et al., 1981a).
It would be quite wrong to draw con-
clusions from experience with breast
cancer about the outcome of endocrine
therapy or the prognosis in carcinoma of
the cervix, simply because some of both
types of cancer contain REs. The concen-
trations of both REC and REN are lower
in carcinoma ofcervix than in carcinoma of
the breast (Leake et al., 198lb; Pegoraro
et al., 1980) and other, more subtle, differ-
ences may exist. However, it is most
encouraging to note that two controlled
studies of oestrogen therapy combined
with radiotherapy, as the primary treat-
ment of carcinoma of the cervix, have
shown a clearandsubstantialimprovement
in the 5-year survival of patients given
oestrogens (Runge, 1959; Sugimori et al.,
1976).
If the mode of action of oestrogens in
carcinoma of the cervix is similar to that
in carcinoma of breast, anti-oestrogens
may be equally effective (Ingle et al.,
1981) and the measurement of proges-
terone receptors may also be valuable
(Barnes et al., 1980).
This study was supported by the S.A. Medical
Research Council through the Preclinical Diagnostic
Chemistry Research Group.
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